fig1

Current landscape and future directions for systemic treatments of hepatocellular carcinoma

Figure 1. Treatment strategy for HCC with systemic therapies. BCLC: Barcelona clinic liver cancer; ECOG: eastern cooperative oncology group; HCC: hepatocellular carcinoma; AFP: alpha-fetoprotein.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/